|
|
 | | | |
- close
- close
- close
- close
Takeda Pharmaceutical (TKPHF) |
The Times of India
Jun 13
Comment
India’s largest drug maker by market capitalization Sun Pharma on Wednesday said that it will pay Pfizer and Japanese drug maker Takeda $550 million jointly to settle a patent infringement suit in the US on generic pantoprazole, an anti-acidity...
The Hindu Business Line
Jun 12
Comment
India’s Sun Pharmaceuticals and Israel’s Teva will pay a sum of $2.15 billion to Pfizer and Takeda as part of patent infringement settlement for acid reflux medicine Protonix in the US.“Und...
FierceBiotech
Jun 11
Comment
Last month, Millennium CEO Deborah Dunsire stepped down and company veteran Anna Protopapas stepped in as president of the company, which will no longer operate as autonomously as it had before the reorganization. The reorganization will also come...
Benzinga
Jun 1
Comment
Takeda Pharmaceutical Company Limited (OTC: TKPYY) today announced interim
data from a Phase 1/2, open-label, multicenter study with ADCETRIS®
(brentuximab vedotin) in pediatric patients diagnosed with CD30-positive
relapsed...
FiercePharma
May 22
Comment
Amag Pharmaceuticals and partner Takeda have run into a snag in Switzerland. Japan-based Takeda is recalling a batch of Amag's anemia drug Feraheme, sold as Rienso in the Swiss market, after several reports of hypersensitivity reactions, one...
FiercePharma
May 10
Comment
CEO Deborah Dunsire is retiring from Millennium, the unit Takeda bought about 5 years ago, as Millennium's oncology R&D is rolled up into the parent company's global research organization.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
